Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

617 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk of herpes zoster in patients receiving anti-TNF-α in the prospective French RATIO registry.
Serac G, Tubach F, Mariette X, Salmon-Céron D, Ravaud P, Lioté F, Laharie D, Ziza JM, Marguerie L, Bonnet C, Falgarone G, Nicolas N, Lortholary O, Chosidow O. Serac G, et al. Among authors: chosidow o. J Invest Dermatol. 2012 Mar;132(3 Pt 1):726-9. doi: 10.1038/jid.2011.383. Epub 2011 Nov 24. J Invest Dermatol. 2012. PMID: 22113472 Free article. No abstract available.
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry.
Salmon-Ceron D, Tubach F, Lortholary O, Chosidow O, Bretagne S, Nicolas N, Cuillerier E, Fautrel B, Michelet C, Morel J, Puéchal X, Wendling D, Lemann M, Ravaud P, Mariette X; RATIO group. Salmon-Ceron D, et al. Among authors: chosidow o. Ann Rheum Dis. 2011 Apr;70(4):616-23. doi: 10.1136/ard.2010.137422. Epub 2010 Dec 21. Ann Rheum Dis. 2011. PMID: 21177290
Switches between biologics in patients with moderate-to-severe psoriasis: results from the French cohort PSOBIOTEQ.
Curmin R, Guillo S, De Rycke Y, Bachelez H, Beylot-Barry M, Beneton N, Chosidow O, Dupuy A, Joly P, Jullien D, Richard MA, Viguier M, Sbidian E, Paul C, Mahé E, Tubach F; PSOBIOTEQ Study Group. Curmin R, et al. Among authors: chosidow o. J Eur Acad Dermatol Venereol. 2022 Nov;36(11):2101-2112. doi: 10.1111/jdv.18409. Epub 2022 Jul 22. J Eur Acad Dermatol Venereol. 2022. PMID: 35793473 Free PMC article.
Phototoxicity and photocarcinogenesis associated with voriconazole.
Epaulard O, Leccia MT, Blanche S, Chosidow O, Mamzer-Bruneel MF, Ravaud P, Thiebaut A, Villier C, Lortholary O. Epaulard O, et al. Among authors: chosidow o. Med Mal Infect. 2011 Dec;41(12):639-45. doi: 10.1016/j.medmal.2011.09.016. Epub 2011 Nov 3. Med Mal Infect. 2011. PMID: 22055586 Review.
Factors associated with the choice of the first biologic in psoriasis: real-life analysis from the Psobioteq cohort.
Sbidian E, Giboin C, Bachelez H, Paul C, Beylot-Barry M, Dupuy A, Viguier M, Lacour JP, Schmutz JL, Bravard P, Mahé E, Beneton N, Misery L, Delaporte E, Modiano P, Barbarot S, Regnier E, Jullien D, Richard MA, Joly P, Tubach F, Chosidow O. Sbidian E, et al. Among authors: chosidow o. J Eur Acad Dermatol Venereol. 2017 Dec;31(12):2046-2054. doi: 10.1111/jdv.14406. Epub 2017 Jul 16. J Eur Acad Dermatol Venereol. 2017. PMID: 28609574 Free article.
Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQ.
Masson Regnault M, Castañeda-Sanabria J, Diep Tran MHT, Beylot-Barry M, Bachelez H, Beneton N, Chosidow O, Dupuy A, Joly P, Jullien D, Mahé E, Richard MA, Viguier M, Tubach F, Sbidian E, Paul C; PsoBioTeq Study Group. Masson Regnault M, et al. Among authors: chosidow o. J Eur Acad Dermatol Venereol. 2020 Feb;34(2):293-300. doi: 10.1111/jdv.15878. Epub 2019 Oct 17. J Eur Acad Dermatol Venereol. 2020. PMID: 31419355 Clinical Trial.
Characteristics of patients with psoriasis with Psoriasis Area and Severity Index < 10 treated with biological agents: results from the French PsoBioTeq cohort.
Beylot-Barry M, Seneschal J, Tran D, Bachelez H, Beneton N, Dupuy A, Joly P, Jullien D, Mahé E, Paul C, Richard MA, Sbidian E, Viguier M, Chosidow O, Tubach F. Beylot-Barry M, et al. Among authors: chosidow o. Br J Dermatol. 2021 Nov;185(5):1052-1054. doi: 10.1111/bjd.20585. Epub 2021 Aug 31. Br J Dermatol. 2021. PMID: 34128543 No abstract available.
Biologic tapering for patients with psoriasis with low disease activity: data from the French PsoBioTeq Registry.
Aubert H, Arlegui H, De Rycke Y, Bachelez H, Beylot-Barry M, Dupuy A, Joly P, Jullien D, Mahé E, Paul C, Richard MA, Sbidian E, Viguier M, Chosidow O, Tubach F, Bénéton N; PsoBioTeq Study Group. Aubert H, et al. Among authors: chosidow o. Br J Dermatol. 2023 Jan 23;188(1):150-152. doi: 10.1093/bjd/ljac024. Br J Dermatol. 2023. PMID: 36689510 No abstract available.
Clinical features, therapeutic choice and response by phototype in psoriasis: analysis of the French PsoBioTeq cohort.
Salle R, Tubach F, Arlegui H, Curmin R, Viguier M, Beylot-Barry M, Dupuy A, Beneton N, Joly P, De Rycke Y, Jullien D, Mahé E, Paul C, Richard MA, Bachelez H, Zago M, Chosidow O, Sbidian É; PsoBioTeq. Salle R, et al. Among authors: chosidow o. Clin Exp Dermatol. 2023 Oct 25;48(11):1238-1246. doi: 10.1093/ced/llad233. Clin Exp Dermatol. 2023. PMID: 37409606
617 results